Humacyte, Inc.
HUMANASDAQHealthcare● Active
$1.45
+$0.07(+5.07%)
Market Cap$243600000
P/E Ratio—
52W High$2.84
52W Low$0.547
Humacyte, Inc.（HUMA）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · HUMA · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($40.83M) | ($148.70M) | ($110.78M) | ($11.96M) | ($26.48M) |
| Depreciation & Amort. | $5.33M | $7.19M | $7.72M | $8.21M | $8.24M |
| Stock-Based Comp. | $9.75M | $6.14M | $6.83M | $6.18M | $10.15M |
| Change in Working Capital | ($23.39M) | $0.31M | $6.57M | $1.03M | ($0.56M) |
| Net Cash from Operations | ($105.04M) | ($98.12M) | ($73.31M) | ($71.13M) | ($81.19M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.88M) | ($1.57M) | ($2.28M) | ($1.05M) | ($0.22M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | ($10.11M) | ($8.00M) |
| Sales of Investments | $0.00M | $0.00M | $2.11M | $16.00M | $0.00M |
| Net Cash from Investing | ($0.88M) | ($1.57M) | ($0.17M) | $4.84M | ($8.22M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $36.38M | ($2.58M) | $5.70M | ($1.98M) | $27.93M |
| Net Cash from Financing | $61.49M | $114.18M | $4.51M | ($1.45M) | $266.98M |
| Free Cash Flow | |||||
| Free Cash Flow | ($105.93M) | ($99.69M) | ($75.58M) | ($72.18M) | ($81.41M) |
| FCF Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · M
深入了解Humacyte, Inc.
关于Humacyte, Inc.（HUMA）现金流量表
Humacyte, Inc. 2025财年经营活动现金流($0.11B)，自由现金流($0.11B)（FCF利润率-5197.55%），资本支出($0.00B)。
常见问题
HUMA · 4 问Humacyte, Inc. 2025财年自由现金流($0.11B)，同比down6.3%。
HUMA free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10